Navigation Links
Alexandria Real Estate Equities, Inc. Reports Third Quarter 2007 Results
Date:11/5/2007

Highlights ----------

Third Quarter 2007: - Third Quarter 2007 Funds from Operations (FFO) Per Share (Diluted) of $1.45, up 10%, Compared to Third Quarter 2006 FFO Per Share (Diluted) of

$1.32

- Third Quarter 2007 Total Revenues up 23%, FFO Available to Common

Stockholders up 21%

- Third Quarter 2007 Earnings Per Share (Diluted) of $0.68, up 21%,

Compared to Third Quarter 2006 Earnings Per Share (Diluted) of $0.56

- Executed 41 Leases for 445,000 Rentable Square Feet - Third Quarter 2007 GAAP Rental Rate Increase of 7.4% on Renewed/Released

Space - Third Quarter 2007 GAAP Same Property Revenues Less Operating Expenses up

4.1%

- Closed $200 Million Secured Loan

- Sold Five Real Estate Assets for Approximately $41 Million - Acquired Twelve Properties Aggregating 836,684 Rentable Square Feet

- Executed MaRS Centre Ground Lease in Toronto, Canada for Planned

Development of One Property Aggregating 770,000 Rentable Square Feet

- Completed Ground-Up Development of One Property in Mission Bay

Aggregating 157,340 Rentable Square Feet

- Commenced Ground-Up Development of One Property in Mission Bay

Aggregating 158,000 Rentable Square Feet

- Commenced First Ground-Up Development of Two Properties in China

Aggregating 280,000 Rentable Square Feet

- Completed Redevelopment of Multiple Spaces at Three Properties

Aggregating 47,722 Rentable Square Feet - Closed Follow-on Common Stock Offering with Net Proceeds of Approximately

$217 Million

PASADENA, Calif., Nov. 5 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE:

SOURCE Alexandria Real Estate Equities, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Coherent Announces Restatement Related to Stock-Based Compensation
2. Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. QMed, Inc. Reports July Medicare SNP Enrollments
5. Phlo Affiliate Reports Expanded Coverage to Oregon Border
6. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
7. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
8. Carrington Reports Second Quarter 2007 Results
9. Avitar Reports Third Quarter Financial Results for Fiscal 2007
10. Response Genetics Reports Second Quarter 2007 Financial Results
11. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... Nearly 600 medical research executives, scientists, policy makers, ... and innovative funding strategies at the inaugural Partnering ... the Washington-based center of the Milken Institute, convened ... to turn a scientific discovery into an accessible therapy. ...
(Date:12/2/2009)... - Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (TSX:ONC; ... its previously announced unit offering, the underwriters have exercised ... 637,500 units. Each unit is comprised of one common ... and was sold at a price of US$3.00 per ...
(Date:12/2/2009)... TechConnect World, an event bringing together the ... cleantech, nanotech, biotech and MEMS, announced the December ... ,, Now in its 14th year, TechConnect World, ... Institute (NSTI), and the Clean Technology and Sustainable ...
(Date:12/2/2009)... Dairy, Inc.,("Emerald Dairy" or the "Company") (OTC Bulletin Board: ... formula, milk powder and,soybean products in China, today announced ... of US Food & Drink Executive, a quarterly magazine ... and beverage industry. , The ...
Breaking Biology Technology:Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 2
... today,announced that John Bennett, head of business development, ... during the Biotechnology Industry,Organization (BIO) International Convention in ... and an update on Celator,s clinical,development programs. The ... at 3:30 PDT in Room 3 of the ...
... Transaction reinforces Deloitte,s leading position in the life sciences ... ... June 16 Deloitte has announced today an,agreement to acquire Recombinant ... firm. Included in the,acquisition is Recap,s unique database that provides more ...
... ROSH HA,AYIN, Israel, June 16 ,EnzySurge Ltd. (EnzySurge), ... management, recently announced the formation of its,Scientific Advisory ... with diversified expertise in chronic wounds.,The Company named ... Diane L.,Krasner, PhD RN, FAAN, Joseph L. Mills, ...
Other Biology Technology:Deloitte Agrees to Acquire Recombinant Capital, A Leading Life Sciences Subscription Database and Advisory Services Firm 2EnzySurge, Maker of DermaStream(TM), Announces the Formation of its Scientific Advisory Board 2EnzySurge, Maker of DermaStream(TM), Announces the Formation of its Scientific Advisory Board 3EnzySurge, Maker of DermaStream(TM), Announces the Formation of its Scientific Advisory Board 4
(Date:12/4/2009)... Gardens, Kew and the Natural History Museum believe that ... previously thought, with many commonly grown plants such ... "meat eaters". A review paper, Murderous plants: Victorian Gothic, ... today (4 December 2009) in the Botanical Journal ...
(Date:12/4/2009)... Using a new mathematical model of heart cells, University ... critical enzyme, calmodulin kinase II (CaM kinase), disrupts the ... study, which also involved Columbia University, was published online ... . , "Recently, researchers have developed great interest ...
(Date:12/3/2009)... the 1980s, Harald zur Hausen and his co-workers discovered ... cancer. Scientists soon found out how these pathogens cause ... main culprits are viral proteins E6 and E7. Both ... cell growth. , Professor Dr. Frank Rsl and ...
Breaking Biology News(10 mins):Scientists think 'killer petunias' should join the ranks of carnivorous plants 2U-Iowa study helps advance heart-related research 2Papillomavirus silences innate immune response 2The Nations Largest Nonprofit Healthcare System Ascension Health Praises Step Forward in Health Reform Debate 57443 1The Nations Largest Nonprofit Healthcare System Ascension Health Praises Step Forward in Health Reform Debate 57443 2HealthSouth Announces Date of 2009 Third Quarter Earnings Conference Call 57441 1HealthSouth Announces Date of 2009 Third Quarter Earnings Conference Call 57441 2Health Insurance Reform DAILY MYTHBUSTER 3A Constitutionality of Health Insurance Reform 57439 1Health Insurance Reform DAILY MYTHBUSTER 3A Constitutionality of Health Insurance Reform 57439 2Health Insurance Reform DAILY MYTHBUSTER 3A Constitutionality of Health Insurance Reform 57439 3
... angina patients placed on beta-blocker therapy corresponds to specific ... researchers at Washington University School of Medicine in St. ... City. The study appears in the September 28, 2005 ... , "In our investigation of acute coronary syndrome (ACS) ...
... in the region now known as Uganda's Kibale ... a primate still in decline. The logging practice, ... ecological balance for these monkeys, leading to behavioral ... infections. , The researchers focused on three primate ...
... in the region now known as Uganda's Kibale ... a primate still in decline. The logging practice, ... ecological balance for these monkeys, leading to behavioral ... infections. , The researchers focused on three primate ...
Other Biology News:Survival of heart patients on beta-blockers varies greatly with genetic variation 2Survival of heart patients on beta-blockers varies greatly with genetic variation 3Survival of heart patients on beta-blockers varies greatly with genetic variation 4President Bush's cut to AIDS prevention in Africa would be devastating 2President Bush's cut to AIDS prevention in Africa would be devastating 3Affymetrix and ParAllele Launch Industry's Most Comprehensive Product Line for Targeted Genotyping 2Affymetrix and ParAllele Launch Industry's Most Comprehensive Product Line for Targeted Genotyping 3
... Dunbar (1994) • This book describes ... methods for preparing samples for protein ... radiometric and bioluminescence-enhanced detection systems are ... the detection and characterization of glycoprotein ...
...
See product name for description....
... PhastGel DNA Silver Staining Kit, ... polyacrylamide gels.Separate proteins and peptides on ... time and improve reproducibility with precast ... detection sensitivity comparable to that of ...
Biology Products: